Treatment Registry

Molecule

Semaglutide

Approved product exists

An FDA-approved semaglutide product exists. The register holds 548 single-ingredient programs, 213 with a comparable monthly price, plus 2 combined programs containing semaglutide. Combined program totals are excluded from single-ingredient prices. Classification recorded August 2026.

Forms

Programs with formulation not established

More columns to the right? Scroll across the table to see all details.

EntryProviderFormRecorded price
with its payment basis
Last verifiedLink
EntryTR-0422ProviderAbundRXFormNot recordedRecorded price$99
Published figure · Semaglutide-based care starting figure; billing period unknown

Initial payment not verified

Recurring price conditions not established

Prescription and individual eligibility required. This published figure does not establish a full payable invoice, payment interval or automatic renewal.

Last verifiedOctober 2026Record
EntryTR-0495ProviderDoctorAdamFormSublingualRecorded price$129
Published figure · Advertised monthly starting program; invoice unverified

Initial payment not verified

Recurring price conditions not established

Prescription and individual clinical eligibility required. Starting advertisement; selected dose and final invoice are not established.

Last verifiedOctober 2026Record
EntryTR-1058ProviderHormonally BalancedFormInjection · device not recordedRecorded priceNo comparable monthly priceLast verifiedOctober 2026Record
EntryTR-1088ProviderJM Integrated HealthFormOral · dosage form not recordedRecorded priceNo comparable monthly priceLast verifiedOctober 2026Record

Combined programs containing semaglutide

These are whole-program records. Their totals do not price this ingredient separately.

A compounded preparation is not itself an FDA-approved product, so each form is recorded and priced separately rather than rolled together.